In trading on Monday, shares of Valeant Pharmaceuticals International ( NYSE: VRX ) touched a new 52-week high of $116.36/share. That's a 99.42% rise, or $58.01 per share from the 52-week low of $58.35 set back on 12/31/2012. That means at today's intraday high, any investor who purchased VRX stock any time over the past 52 weeks has an unrealized gain, including company insiders.